Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 12775730

Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2003 Jun 1
First author
Rothenberg ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2003 Jun 1;21(11):2049-51. doi: 10.1200/JCO.2003.03.074.
    note
    Source null
    related pmid
    12775727
    relationship
    Comment in

Authors and identifiers

  1. name
    Rothenberg ML
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Bigelow RH
    type
    Author
  4. name
    Berlin JD
    type
    Author
  5. name
    Marshall JL
    type
    Author
  6. name
    Ramanathan RK
    type
    Author
  7. name
    Hart LL
    type
    Author
  8. name
    Gupta S
    type
    Author
  9. name
    Garay CA
    type
    Author
  10. name
    Burger BG
    type
    Author
  11. name
    Le Bail N
    type
    Author
  12. name
    Haller DG
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rothenberg ML
    type
    Author
  2. name
    Oza AM
    type
    Author
  3. name
    Bigelow RH
    type
    Author
  4. name
    Berlin JD
    type
    Author
  5. name
    Marshall JL
    type
    Author
  6. name
    Ramanathan RK
    type
    Author
  7. name
    Hart LL
    type
    Author
  8. name
    Gupta S
    type
    Author
  9. name
    Garay CA
    type
    Author
  10. name
    Burger BG
    type
    Author
  11. name
    Le Bail N
    type
    Author
  12. name
    Haller DG
    type
    Author
bibliography ids
  1. nci-bib-df5762d285d658ac1f0528c2
book metadata
content sha256
1c8fd0d1f6f541aa0b0eca907ec8cc9ca09f62b9727e43038d9c04fe99371226
document type
citation
dois
  1. 10.1200/JCO.2003.11.126
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12775730
immutable id
pubmed:12775730@1c8fd0d1f6f541aa0b0eca907ec8cc9ca09f62b9727e43038d9c04fe99371226
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2059-69
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2003 Jun 1;21(11):2049-51. doi: 10.1200/JCO.2003.03.074.
    note
    Source null
    related pmid
    12775727
    relationship
    Comment in
outcomes validated
false
pmid
12775730
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
ae78b9986d5c058ff3532e820ea23d358f6c5315ef4bab14bee474c45c5a9c2b
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Jun 1
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
  8. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12775730/
title
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

Preserved source evidence · Independent clinical review pending · Not medical advice